S&P 500   4,967.23 (-0.88%)
DOW   37,986.40 (+0.56%)
QQQ   414.65 (-2.07%)
AAPL   165.00 (-1.22%)
MSFT   399.12 (-1.27%)
META   481.07 (-4.13%)
GOOGL   154.09 (-1.23%)
AMZN   174.63 (-2.56%)
TSLA   147.05 (-1.92%)
NVDA   762.00 (-10.00%)
AMD   146.64 (-5.44%)
NIO   3.80 (-5.00%)
BABA   69.07 (+0.28%)
T   16.51 (+1.10%)
F   12.14 (+0.66%)
MU   106.77 (-4.61%)
GE   148.06 (-3.19%)
CGC   7.93 (+1.28%)
DIS   112.61 (+0.16%)
AMC   3.16 (+8.22%)
PFE   26.00 (+2.40%)
PYPL   62.31 (+0.34%)
XOM   119.88 (+1.15%)
S&P 500   4,967.23 (-0.88%)
DOW   37,986.40 (+0.56%)
QQQ   414.65 (-2.07%)
AAPL   165.00 (-1.22%)
MSFT   399.12 (-1.27%)
META   481.07 (-4.13%)
GOOGL   154.09 (-1.23%)
AMZN   174.63 (-2.56%)
TSLA   147.05 (-1.92%)
NVDA   762.00 (-10.00%)
AMD   146.64 (-5.44%)
NIO   3.80 (-5.00%)
BABA   69.07 (+0.28%)
T   16.51 (+1.10%)
F   12.14 (+0.66%)
MU   106.77 (-4.61%)
GE   148.06 (-3.19%)
CGC   7.93 (+1.28%)
DIS   112.61 (+0.16%)
AMC   3.16 (+8.22%)
PFE   26.00 (+2.40%)
PYPL   62.31 (+0.34%)
XOM   119.88 (+1.15%)
S&P 500   4,967.23 (-0.88%)
DOW   37,986.40 (+0.56%)
QQQ   414.65 (-2.07%)
AAPL   165.00 (-1.22%)
MSFT   399.12 (-1.27%)
META   481.07 (-4.13%)
GOOGL   154.09 (-1.23%)
AMZN   174.63 (-2.56%)
TSLA   147.05 (-1.92%)
NVDA   762.00 (-10.00%)
AMD   146.64 (-5.44%)
NIO   3.80 (-5.00%)
BABA   69.07 (+0.28%)
T   16.51 (+1.10%)
F   12.14 (+0.66%)
MU   106.77 (-4.61%)
GE   148.06 (-3.19%)
CGC   7.93 (+1.28%)
DIS   112.61 (+0.16%)
AMC   3.16 (+8.22%)
PFE   26.00 (+2.40%)
PYPL   62.31 (+0.34%)
XOM   119.88 (+1.15%)
S&P 500   4,967.23 (-0.88%)
DOW   37,986.40 (+0.56%)
QQQ   414.65 (-2.07%)
AAPL   165.00 (-1.22%)
MSFT   399.12 (-1.27%)
META   481.07 (-4.13%)
GOOGL   154.09 (-1.23%)
AMZN   174.63 (-2.56%)
TSLA   147.05 (-1.92%)
NVDA   762.00 (-10.00%)
AMD   146.64 (-5.44%)
NIO   3.80 (-5.00%)
BABA   69.07 (+0.28%)
T   16.51 (+1.10%)
F   12.14 (+0.66%)
MU   106.77 (-4.61%)
GE   148.06 (-3.19%)
CGC   7.93 (+1.28%)
DIS   112.61 (+0.16%)
AMC   3.16 (+8.22%)
PFE   26.00 (+2.40%)
PYPL   62.31 (+0.34%)
XOM   119.88 (+1.15%)
OTCMKTS:FCUUF

Fission Uranium (FCUUF) Stock Price, News & Analysis

$0.79
+0.02 (+2.60%)
(As of 04/18/2024 ET)
Today's Range
$0.77
$0.80
50-Day Range
$0.70
$0.84
52-Week Range
$0.40
$0.99
Volume
97,703 shs
Average Volume
241,347 shs
Market Capitalization
$659.27 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$1.90

Fission Uranium MarketRank™ Stock Analysis

Analyst Rating
Buy
3.00 Rating Score
Upside/​Downside
140.5% Upside
$1.90 Price Target
Short Interest
Bearish
1.17% of Shares Sold Short
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
0.35mentions of Fission Uranium in the last 14 days
Based on 5 Articles This Week
Insider Trading
N/A
Proj. Earnings Growth
N/A

Overall MarketRank

New Rank-Based ScoringMarketRank is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.

0.89 out of 5 stars

FCUUF stock logo

About Fission Uranium Stock (OTCMKTS:FCUUF)

Fission Uranium Corp. engages in the acquisition, exploration, and development of uranium resource properties in Canada. Its flagship property is the 100% owned Patterson Lake South property with 17 contiguous mineral claims covering an area of 31,039 ha located in the Athabasca Basin region of Saskatchewan, Canada. The company was incorporated in 2013 and is headquartered in Kelowna, Canada.

FCUUF Stock Price History

FCUUF Stock News Headlines

Tiny Biotech Stock Wins $75 Billion Patent
A little-known biotech has been quietly working on revolutionary treatments for neurodegenerative diseases. Most people have never heard of them... but those in the know have been taking notice. Jeff Bezos cut them a check for $130 million. Fidelity Biosciences for a further $217 million. They've even had several collaborative partnerships with much larger companies like Biogen, Sanofi, and Takeda.
Fission Uranium Corp
Tiny Biotech Stock Wins $75 Billion Patent
A little-known biotech has been quietly working on revolutionary treatments for neurodegenerative diseases. Most people have never heard of them... but those in the know have been taking notice. Jeff Bezos cut them a check for $130 million. Fidelity Biosciences for a further $217 million. They've even had several collaborative partnerships with much larger companies like Biogen, Sanofi, and Takeda.
ATOMIC AGE: Fission Fever
Fission Announces $75 Million Bought Deal Financing
Fission Uranium Corp FCUUF
FISSION FILES FINAL BASE SHELF PROSPECTUS
Fission Closes $9.2 Million Bought Deal Financing
See More Headlines
Receive FCUUF Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Fission Uranium and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Today
4/19/2024
Next Earnings (Estimated)
5/15/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Industry
Metal mining
Sub-Industry
N/A
Current Symbol
OTCMKTS:FCUUF
CIK
N/A
Employees
17
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
$1.90
High Stock Price Target
$1.90
Low Stock Price Target
$1.90
Potential Upside/Downside
+140.5%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
1 Analysts

Profitability

Net Income
$-6,610,000.00
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A
Book Value
$0.43 per share

Miscellaneous

Free Float
827,926,000
Market Cap
$659.27 million
Optionable
Not Optionable
Beta
2.26
7 Stocks to Own Before the 2024 Election Cover

Looking to avoid the hassle of mudslinging, volatility, and uncertainty? You'd need to be out of the market, which isn’t viable. So where should investors put their money? Find out with this report.

Get This Free Report

Key Executives

  • Mr. Ross E. McElroy B.Sc. (Age 60)
    P.Geo., P.Geol, CEO, Technical Team Leader, President, COO & Director
    Comp: $698.93k
  • Mr. Chris Sammartino CPA
    CGA, Chief Financial Officer
  • Mr. Bob Hemmerling
    Senior Manager of Investor Relations
  • Mr. Kanan Sarioglu P.Geo.
    Vice President of Exploration
  • Mr. James Haley P.Geo.
    Senior Geologist

FCUUF Stock Analysis - Frequently Asked Questions

Should I buy or sell Fission Uranium stock right now?

1 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Fission Uranium in the last year. There are currently 1 buy rating for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" FCUUF shares.
View FCUUF analyst ratings
or view top-rated stocks.

What is Fission Uranium's stock price target for 2024?

1 equities research analysts have issued 1 year target prices for Fission Uranium's stock. Their FCUUF share price targets range from $1.90 to $1.90. On average, they predict the company's share price to reach $1.90 in the next twelve months. This suggests a possible upside of 140.5% from the stock's current price.
View analysts price targets for FCUUF
or view top-rated stocks among Wall Street analysts.

How have FCUUF shares performed in 2024?

Fission Uranium's stock was trading at $0.8188 at the start of the year. Since then, FCUUF shares have decreased by 3.5% and is now trading at $0.79.
View the best growth stocks for 2024 here
.

Are investors shorting Fission Uranium?

Fission Uranium saw a increase in short interest during the month of March. As of March 31st, there was short interest totaling 9,787,400 shares, an increase of 5.1% from the March 15th total of 9,313,500 shares. Based on an average daily volume of 476,400 shares, the short-interest ratio is presently 20.5 days.
View Fission Uranium's Short Interest
.

When is Fission Uranium's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Wednesday, May 15th 2024.
View our FCUUF earnings forecast
.

How do I buy shares of Fission Uranium?

Shares of FCUUF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (OTCMKTS:FCUUF) was last updated on 4/19/2024 by MarketBeat.com Staff

From Our Partners